Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN16509838Phase 3Completed
Phase 3, randomised, double-blind trial in aphthosis (RAS) comparing Bexident Aftas Gel with Placebo gel (2 arms). Primary endpoint: Ulcer pain by visual analogue scale. Started Oct 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN16509838.